Subject Index Volume 99 (2004)

Journal of Controlled Release 99 (2004) 465 – 467 www.elsevier.com/locate/jconrel

Subject Index Volume 99 (2004) Absorption enhancer, (99) 63 Aciclovir, (99) 41 Albumin, (99) 357 Amphiphile–DNA complexes, (99) 177 Anterior chamber, (99) 241 Antibiotic, (99) 127 Antioxidant, (99) 403 Antisense, (99) 139 Aqueous dispersion, (99) 1 Basic fibroblast growth factor, (99) 103, (99) 281 Benzyl benzoate (BB), (99) 207 Biodistribution, (99) 329 Blood–brain barrier, (99) 259 Bone ingrowth, (99) 103 Brain metastases, (99) 259 Brain perfusion, (99) 259 Brain uptake, (99) 259 Buccal delivery, (99) 73 Caco-2, (99) 383 Carboxyfluorescein, (99) 393 Cellular delivery, (99) 139 Cellular uptake, (99) 177 Characterization, (99) 15 Chitosan acetate, (99) 15 Cholesterol, (99) 231 Coating, (99) 1, (99) 127 Colloidal stabilization, (99) 423 Confocale laser scanning microscopy, (99) 53 Controlled release, (99) 231 Cubic liquid crystal, (99) 217 Cyclodextrin, (99) 393 h cyclodextrin, (99) 393 Cytoprotection, (99) 63 Cytoskeleton, (99) 157 Cytotoxicity, (99) 157 Dendrimer, (99) 139, (99) 445 Dendritic poly(l-lysine), (99) 329

doi:10.1016/S0168-3659(04)00424-9

Dipalmitoylphosphatidylcholine, (99) 357 Diphtheria-specific antibodies, (99) 345 DNA array, (99) 139 Drug targeting, (99) 301 Dry powder aerosols, (99) 357 EDAC/NHS, (99) 383 EGFR, (99) 139 Electroporation, (99) 393 Emulsification solvent evaporation, (99) 271 Endocytosis, (99) 435 Enhancer, (99) 113 Ethyl butanoate, (99) 315 Ethyl decanoate, (99) 315 Ethyl hexanoate, (99) 315 Ethyl octanoate, (99) 315 Eye, (99) 241 Fine particle fraction, (99) 357 Flow cytometry, (99) 383 Fluorescence, (99) 53 Gelatin, (99) 41 Gelation, (99) 207 Gene delivery, (99) 177, (99) 329, (99) 423, (99) 445 Gene Delivery, (99) 157 Gene silencing, (99) 139 Gene therapy, (99) 329 Glycerol-l-lactide, (99) 103 Growth inhibition, (99) 27 Haemophilus influenzae type b (Hib) antigens, (99) 345 Hair follicle, (99) 53 Helicobacter pylori, (99) 27 Histopathology, (99) 63 HIV-1 Tat, (99) 435 HPMA copolymer, (99) 301 Hydrolysis, (99) 403 Hydrophobicity, (99) 113

466 Hydroxyapatite, (99) 127 Hydroxypropyl h-cyclodextrin, (99) 393 Ibuprofen, (99) 73 In situ adherence assay, (99) 27 In vitro, (99) 207 In vitro ex vivo and in vivo release, (99) 73 In vivo antitumor activity, (99) 83 Intestinal tract, (99) 199 Intraocular, (99) 41 l-Arginine, (99) 445 Lauric acid, (99) 217 l-dopa, (99) 293 l-dopa prodrugs, (99) 293 l-Glutamine, (99) 63 Lipiodolized emulsion, (99) 167 Lipobeads, (99) 27 Lipophilicity, (99) 113 Lipoplex, (99) 423 Liposomes, (99) 293 Local gene delivery in vivo, (99) 167 Malaria vaccines, (99) 345 Man, (99) 199 Maximum tolerated dose, (99) 83 Mechanism, (99) 271 Metoclopramide, (99) 207 Microdialysis, (99) 293 Microparticle, (99) 271 Microporous-controlled tablets, (99) 415 Monolaurin, (99) 217 Morphology, (99) 271 Mucoadhesion, (99) 73 Nanoparticles, (99) 53, (99) 157 Nonviral, (99) 177 Non-viral gene transfer, (99) 435 Ophthalmic drug delivery, (99) 241 Parkinson’s disease, (99) 293 PEGylation, (99) 167 Pellets, (99) 1 Penetration enhancer, (99) 113 Permeation enhancer, (99) 113 PFG-MAS-NMR, (99) 315 P-glycoprotein, (99) 259 Pharmacokinetics, (99) 83 Phosphatidyl ethanolamine, (99) 27 pH-sensitive PEG lipids, (99) 423 Piroxicam, (99) 393 Plasmid DNA, (99) 445 Plasticizer, (99) 1, (99) 415 PLGA microspheres, (99) 41

Subject Index Volume 99 (2004) PLGA nanospheres, (99) 383 PMMA, (99) 231 Poly (lactide-co-glycolide) (PLGA), (99) 207 Poly(q-caprolactone), (99) 231, (99) 415 Poly(ethylene glycol), (99) 415 Poly(lactide-co-glycolide), (99) 271 Polyethylenimine, (99) 167 Polymer blend, (99) 1 Polymeric films, (99) 73 Polymeric micelles, (99) 83 Polyplex, (99) 445 Poorly water-soluble drugs, (99) 217 Porcine epidermis, (99) 393 Precipitation, (99) 127 Protein transduction domain, (99) 435 Proteolytically/hydrolytically cleavable bond, (99) 301 Pro-vitamin, (99) 403 Pullulan, (99) 157 QSAR, (99) 113 Radiation-guided drug delivery, (99) 369 Receptor-mediated targeting, (99) 27 Release, (99) 127 Release kinetics, (99) 315 Release mechanism, (99) 1 Reservoir, (99) 281 Residence time, (99) 199 Restricted diffusion, (99) 315 Scintigraphy, (99) 199 Serum, (99) 177 Skin, (99) 53 Skin absorption, (99) 113 SPH composite, (99) 199 Spray drying, (99) 15 Spray-drying, (99) 357 Stability, (99) 139 Sterilisation, (99) 41 Supercritical fluids, (99) 231 Superporous hydrogels (SPH), (99) 199 Suppository, (99) 63 Sustained release, (99) 217, (99) 393 Sustained release tablets, (99) 15 Tablet binder, (99) 15 Taurine, (99) 63 Taxanes, (99) 83 Titanium implants, (99) 127 Tocopherol, (99) 403 Topical, (99) 241 Tracheal epithelial cells, (99) 435 Transdermal, (99) 403 Transdermal penetration, (99) 113 Transdermal permeation, (99) 113 Transfection, (99) 157

Subject Index Volume 99 (2004) Transport, (99) 241 Tumor, (99) 423 Tumor blood vessel, (99) 369 Tumor growth delay, (99) 369 Type I collagen, (99) 281

Water sorption, (99) 357 Wheat germ agglutinin, (99) 383 X-ray diffraction, (99) 357 X-ray photoelectron spectroscopy, (99) 357

467